These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9178521)

  • 1. Synthesis, affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors and structure-activity relationships of a series of cyproheptadine analogues.
    Honrubia MA; Rodriguez J; Dominguez R; Lozoya E; Manaut F; Seijas JA; Villaverde MC; Calleja JM; Cadavid MI; Maayani S; Sanz F; Loza MI
    Chem Pharm Bull (Tokyo); 1997 May; 45(5):842-8. PubMed ID: 9178521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproheptadine analogues: synthesis, antiserotoninergic activity, and structure-activity relationships.
    Loza MI; Sanz F; Cadavid MI; Honrubia M; Orallo F; Fontenla JA; Calleja JM; Dot T; Manaut F; Cid MM
    J Pharm Sci; 1993 Nov; 82(11):1090-3. PubMed ID: 8289119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
    Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
    J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
    Pertz HH; Brown AM; Gager TL; Kaumann AJ
    J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
    Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
    Syvälahti E; Penttilä J; Majasuo H; Pälvimäki EP; Laakso A; Hietala J
    Pharmacopsychiatry; 2006 Jan; 39(1):1-8. PubMed ID: 16453246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
    Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
    Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle.
    Baxter GS; Murphy OE; Blackburn TP
    Br J Pharmacol; 1994 May; 112(1):323-31. PubMed ID: 8032658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
    Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
    Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A; Yamada H; Watanabe T; Itahana H; Akuzawa S; Okada M; Ohta M
    Bioorg Med Chem; 2013 Dec; 21(24):7841-52. PubMed ID: 24189186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.